Adam Muzychuk, MD, discusses how AI like the Kane formula is improving outcomes, and why he still urges caution over relying on it for clinical decisions.
Adam Muzychuk, MD, BSc, FRCSC
Advertisement
Articles by Adam Muzychuk, MD, BSc, FRCSC
At ESCRS 2026, Adam Muzychuk, MD, shares real-world data showing the enVista Envy IOL matches clinical trial outcomes, even in eyes with residual refractive error.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
3
EURETINA 2026: Real-world evidence on retinal biosimilars
4
EURETINA 2026: 3 gene therapy programmes for nAMD approaching phase 3 readouts
5